NORTHSTRIVE FUND II LP - 10 Feb 2026 SCHEDULE 13G Report for enVVeno Medical Corp Common Stock, $0.00001 par value per share

Filing Manager: NORTHSTRIVE FUND II LP
Reporting Manager: Braeden Lichti
Security: enVVeno Medical Corp Common Stock, $0.00001 par value per share
Shares outstanding: 656,455 shares
Disclosed Ownership: 33,151 shares
Ownership: 5%
Form type: SCHEDULE 13G
Filing time: 10 Feb 2026, 16:29:24 UTC
Date of event: 10 Feb 2026
Next filing: 20 Feb 2026
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Northstrive Fund II LP	3.1%	20,129	0	20,129	/s/ Braeden Lichti	Braeden Lichti, Manager
Braeden Lichti	5%	33,151	13,022	20,129	/s/ Braeden Lichti	Braeden Lichti